MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCune, D. F.
Right arrow Articles by Piascik, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCune, D. F.
Right arrow Articles by Piascik, M. T.

Vol. 57, Issue 4, 659-666, April 2000

Regulation of the Cellular Localization and Signaling Properties of the alpha 1B- and alpha 1D-Adrenoceptors by Agonists and Inverse Agonists

Dan F. McCune, Stephanie E. Edelmann, Jennifer R. Olges, Ginell R. Post, Bruce A. Waldrop, David J. J. Waugh, Dianne M. Perez, and Michael T. Piascik

The Department of Pharmacology (S.E.E., D.F.M., J.R.O., M.T.P.) and the Vascular Biology Research Group (S.E.E., D.F.M., J.R.O., M.T.P., G.R.P., B.A.W.), The University of Kentucky College of Medicine, The Division of Pharmaceutical Sciences (G.R.P., B.A.W.), The University of Kentucky College of Pharmacy, Lexington, Kentucky; and The Department of Molecular Cardiology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio (D.M.P., D.J.J.W.)

The regulation of the cellular distribution and intracellular signaling properties of the alpha 1B- and alpha 1D- adrenoceptor (alpha 1-AR) subtypes was examined in stably transfected Rat 1 fibroblasts. In unstimulated cells, alpha 1B-AR expression was noted primarily on the cell surface. Treatment with phenylephrine induced internalization of the alpha 1B-AR and promoted association with arrestin 2. The internalized alpha 1B-AR colocalized with the transferrin receptor, an endosomal marker. In unstimulated fibroblasts, the alpha 1D-AR was detected in a perinuclear orientation and was colocalized with arrestin 2 in a compartment also containing the transferrin receptor. After treatment with prazosin, which exhibits inverse agonist properties, the alpha 1D-AR was redistributed from intracellular sites to the cellular periphery and was no longer associated with the transferrin receptor or arrestin 2. alpha 1D-AR-expressing cells exhibited a high degree of basal activity for both inositol phosphate formation and extracellular signal regulated kinase (ERK), which was reduced by treatment with prazosin. In these cells, phenylephrine induced a dose-dependent increase in inositol phosphate formation but had no effect on ERK activity. In alpha 1B -AR-expressing cells, phenylephrine stimulated both inositol phosphate formation and ERK activity. These data show that: 1) there are differences in the cellular localization of the alpha 1-AR subtypes; 2) the alpha 1B-AR exhibits expected G protein-coupled receptor activity regarding cellular localization, agonist-mediated internalization, and coupling to second messengers; and 3) the alpha 1D-AR is constitutively active and, as a result, is localized to intracellular compartments involved in receptor recycling.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. C. Vinci, L. Bellik, S. Filippi, F. Ledda, and A. Parenti
Trophic effects induced by {alpha}1D-adrenoceptors on endothelial cells are potentiated by hypoxia
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2140 - H2147.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Walwyn, C. J. Evans, and T. G. Hales
{beta}-Arrestin2 and c-Src Regulate the Constitutive Activity and Recycling of {micro} Opioid Receptors in Dorsal Root Ganglion Neurons
J. Neurosci., May 9, 2007; 27(19): 5092 - 5104.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Q. Xu, N. Xu, T. Zhang, H. Zhang, Z. Li, F. Yin, Z. Lu, Q. Han, and Y. Zhang
Mammalian Tolloid Alters Subcellular Localization, Internalization, and Signaling of {alpha}1a-Adrenergic Receptors
Mol. Pharmacol., August 1, 2006; 70(2): 532 - 541.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman
Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity
Mol. Pharmacol., January 1, 2006; 69(1): 45 - 55.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Marti, R. Miquel, K. Ziani, R. Gisbert, M. D. Ivorra, E. Anselmi, L. Moreno, V. Villagrasa, D. Barettino, and P. D'Ocon
Correlation between mRNA levels and functional role of {alpha}1-adrenoceptor subtypes in arteries: evidence of {alpha}1L as a functional isoform of the {alpha}1A-adrenoceptor
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1923 - H1932.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. D. Paasche, T. Attramadal, K. Kristiansen, M. P. Oksvold, H. K. Johansen, H. S. Huitfeldt, S. G. Dahl, and H. Attramadal
Subtype-Specific Sorting of the ETA Endothelin Receptor by a Novel Endocytic Recycling Signal for G Protein-Coupled Receptors
Mol. Pharmacol., May 1, 2005; 67(5): 1581 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Wang, C. G. Radu, L. V. Yang, L. A. Bentolila, M. Riedinger, and O. N. Witte
Lysophosphatidylcholine-induced Surface Redistribution Regulates Signaling of the Murine G Protein-coupled Receptor G2A
Mol. Biol. Cell, May 1, 2005; 16(5): 2234 - 2247.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. Uberti, C. Hague, H. Oller, K. P. Minneman, and R. A. Hall
Heterodimerization with {beta}2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of {alpha}1D-Adrenergic Receptors
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 16 - 23.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern
Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. P. Morris, R. R. Price, M. P. Smith, B. Lei, and D. A. Schwinn
Cellular Trafficking of Human {alpha}1a-Adrenergic Receptors Is Continuous and Primarily Agonist-Independent
Mol. Pharmacol., October 1, 2004; 66(4): 843 - 854.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Hague, M. A. Uberti, Z. Chen, C. F. Bush, S. V. Jones, K. J. Ressler, R. A. Hall, and K. P. Minneman
Olfactory receptor surface expression is driven by association with the {beta}2-adrenergic receptor
PNAS, September 14, 2004; 101(37): 13672 - 13676.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Hague, Z. Chen, A. S. Pupo, N. A. Schulte, M. L. Toews, and K. P. Minneman
The N Terminus of the Human {alpha}1D-Adrenergic Receptor Prevents Cell Surface Expression
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 388 - 397.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
T. Kenakin
Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism
Mol. Pharmacol., January 1, 2004; 65(1): 2 - 11.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. A. Uberti, R. A. Hall, and K. P. Minneman
Subtype-Specific Dimerization of {alpha}1-Adrenoceptors: Effects on Receptor Expression and Pharmacological Properties
Mol. Pharmacol., December 1, 2003; 64(6): 1379 - 1390.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Gisbert, F. Perez-Vizcaino, A. L. Cogolludo, M. A. Noguera, M. D. Ivorra, J. Tamargo, and P. D'Ocon
Cytosolic Ca2+ and Phosphoinositide Hydrolysis Linked to Constitutively Active {alpha}1D-Adrenoceptors in Vascular Smooth Muscle
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1006 - 1014.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Chalothorn, D. F. McCune, S. E. Edelmann, K. Tobita, B. B. Keller, R. D. Lasley, D. M. Perez, A. Tanoue, G. Tsujimoto, G. R. Post, et al.
Differential Cardiovascular Regulatory Activities of the {alpha}1B- and {alpha}1D-Adrenoceptor Subtypes
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1045 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Hupfeld, S. Dalle, and J. M. Olefsky
beta -Arrestin 1 down-regulation after insulin treatment is associated with supersensitization of beta 2 adrenergic receptor Galpha s signaling in 3T3-L1 adipocytes
PNAS, January 7, 2003; 100(1): 161 - 166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Chalothorn, D. F. McCune, S. E. Edelmann, M. L. Garcia-Cazarin, G. Tsujimoto, and M. T. Piascik
Differences in the Cellular Localization and Agonist-Mediated Internalization Properties of the alpha 1-Adrenoceptor Subtypes
Mol. Pharmacol., May 1, 2002; 61(5): 1008 - 1016.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Miserey-Lenkei, C. Parnot, S. Bardin, P. Corvol, and E. Clauser
Constitutive Internalization of Constitutively Active Angiotensin II AT1A Receptor Mutants Is Blocked by Inverse Agonists
J. Biol. Chem., February 15, 2002; 277(8): 5891 - 5901.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. A. Waldrop, D. Mastalerz, M. T. Piascik, and G. R. Post
alpha 1B- and alpha 1D-Adrenergic Receptors Exhibit Different Requirements for Agonist and Mitogen-Activated Protein Kinase Activation to Regulate Growth Responses in Rat 1 Fibroblasts
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 83 - 90.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. T. Piascik and D. M. Perez
alpha 1-Adrenergic Receptors: New Insights and Directions
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 403 - 410.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
T. KENAKIN
Inverse, protean, and ligand-selective agonism: matters of receptor conformation
FASEB J, March 1, 2001; 15(3): 598 - 611.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. L. Ferrari and A. Bisello
Cellular Distribution of Constitutively Active Mutant Parathyroid Hormone (PTH)/PTH-Related Protein Receptors and Regulation of Cyclic Adenosine 3',5'-Monophosphate Signaling by {beta}-Arrestin2
Mol. Endocrinol., January 1, 2001; 15(1): 149 - 163.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Gisbert, M. A. Noguera, M. D. Ivorra, and P. D'Ocon
Functional Evidence of a Constitutively Active Population of alpha 1D-Adrenoceptors in Rat Aorta
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 810 - 817.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Ziani, R. Gisbert, M. A. Noguera, M. D. Ivorra, and P. D'Ocon
Modulatory role of a constitutively active population of alpha 1D-adrenoceptors in conductance arteries
Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H475 - H481.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics